Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.260
-0.020 (-0.88%)
At close: Dec 5, 2025, 4:00 PM EST
2.261
+0.001 (0.05%)
After-hours: Dec 5, 2025, 4:18 PM EST
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $127.33 million as of December 5, 2025. Its market cap has increased by 104.71% in one year.
Market Cap
127.33M
Enterprise Value
82.06M
1-Year Change
104.71%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $127.33M, a decrease of -17.37%. That is a compound annual growth rate of -2.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 128.50M | 128.65% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |